These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24555937)

  • 1. Generation of a monoclonal antibody for INI1/hSNF5/BAF47.
    Harada A; Hayashi M; Kuniyoshi Y; Semba Y; Sugahara S; Tachibana T; Ohkawa Y; Fujita M
    Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):49-51. PubMed ID: 24555937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin-remodeling factor INI1/hSNF5/BAF47 is involved in activation of the colony stimulating factor 1 promoter.
    Pan X; Song Z; Zhai L; Li X; Zeng X
    Mol Cells; 2005 Oct; 20(2):183-8. PubMed ID: 16267391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INI1/hSNF5/BAF47 represses c-fos transcription via a histone deacetylase-dependent manner.
    Pan X; Zhai L; Sun R; Li X; Zeng X
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1052-8. PubMed ID: 16219292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.
    Wu DY; Kalpana GV; Goff SP; Schubach WH
    J Virol; 1996 Sep; 70(9):6020-8. PubMed ID: 8709224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.
    Boese A; Sommer P; Holzer D; Maier R; Nehrbass U
    J Gen Virol; 2009 Oct; 90(Pt 10):2503-2512. PubMed ID: 19515827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.
    Caramel J; Quignon F; Delattre O
    Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrase interactor 1 in health and disease.
    Das S
    Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
    Caramel J; Medjkane S; Quignon F; Delattre O
    Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors.
    DeCristofaro MF; Betz BL; Wang W; Weissman BE
    Oncogene; 1999 Dec; 18(52):7559-65. PubMed ID: 10602515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB.
    Betz BL; Strobeck MW; Reisman DN; Knudsen ES; Weissman BE
    Oncogene; 2002 Aug; 21(34):5193-203. PubMed ID: 12149641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human SNF5/INI1 protein facilitates the function of the growth arrest and DNA damage-inducible protein (GADD34) and modulates GADD34-bound protein phosphatase-1 activity.
    Wu DY; Tkachuck DC; Roberson RS; Schubach WH
    J Biol Chem; 2002 Aug; 277(31):27706-15. PubMed ID: 12016208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
    Versteege I; Medjkane S; Rouillard D; Delattre O
    Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.
    Medjkane S; Novikov E; Versteege I; Delattre O
    Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.
    Zhang ZK; Davies KP; Allen J; Zhu L; Pestell RG; Zagzag D; Kalpana GV
    Mol Cell Biol; 2002 Aug; 22(16):5975-88. PubMed ID: 12138206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.
    Grand F; Kulkarni S; Chase A; Goldman JM; Gordon M; Cross NC
    Cancer Res; 1999 Aug; 59(16):3870-4. PubMed ID: 10463572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of INI1/hSNF5 RPT1 and its interactions with the c-MYC:MAX heterodimer provide insights into the interplay between MYC and the SWI/SNF chromatin remodeling complex.
    Sammak S; Allen MD; Hamdani N; Bycroft M; Zinzalla G
    FEBS J; 2018 Nov; 285(22):4165-4180. PubMed ID: 30222246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic interaction of the tumour suppressor protein hSNF5 with dynamin-2 controls endocytosis.
    Alfonso-Pérez T; Domínguez-Sánchez MS; García-Domínguez M; Reyes JC
    Oncogene; 2014 Jun; 33(23):3064-74. PubMed ID: 23851497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA.
    Lee D; Sohn H; Kalpana GV; Choe J
    Nature; 1999 Jun; 399(6735):487-91. PubMed ID: 10365963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SWI/SNF subunit/tumor suppressor BAF47/INI1 is essential in cell cycle arrest upon skeletal muscle terminal differentiation.
    Joliot V; Ait-Mohamed O; Battisti V; Pontis J; Philipot O; Robin P; Ito H; Ait-Si-Ali S
    PLoS One; 2014; 9(10):e108858. PubMed ID: 25271443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.